Kemira Investor Presentation

Our path towards 500 MEUR biobased revenue target advances via 4 tracks 1. CURRENT PORTFOLIO Boost the sales of commercially available biobased products 2. PRODUCT CONVERSION Convert current products to biobased through a change of raw material and feedstock 3. NEW BIOBASED CHEMISTRIES 4. EXPLORATION Kemira APRIL 25, 2023 INVESTOR PRESENTATION New products based on available chemistries Future biobased opportunities through collaborations and exploration 18

View entire presentation